Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.35M Buy
95,000
+90,900
+2,217% +$5.25M 0.01% 1090
2025
Q4
$305K Sell
4,100
-57,900
-93% -$4.17M ﹤0.01% 2365
2025
Q3
$4.53M Buy
+62,000
New +$4.72M 0.02% 714
2025
Q2
Sell
-7,700
Closed -$347K 2524
2025
Q1
$347K Buy
+7,700
New +$456K ﹤0.01% 1692
2023
Q2
Sell
-16,100
Closed -$181K 2383
2023
Q1
$181K Sell
16,100
-2,800
-15% -$35.3K ﹤0.01% 1943
2022
Q4
$182K Buy
18,900
+4,300
+29% +$64.8K ﹤0.01% 1956
2022
Q3
$273K Buy
14,600
+500
+4% +$13.1K ﹤0.01% 2053
2022
Q2
$254K Buy
14,100
+1,700
+14% +$46.2K ﹤0.01% 2128
2022
Q1
$573K Buy
+12,400
New +$649K ﹤0.01% 1545

Other funds holding AFRM

HRT Financial's AFRM Position: Q2 2025 in Review

HRT Financial sold out of Affirm (AFRM) in Q2 2025, closing a stake of 6,040 shares — an estimated $313K sold.

HRT Financial first reported a position in AFRM in Q1 2021 and held it in 6 quarters. The position peaked at $11.3M in Q4 2024. 561 funds tracked by Wall St. Rank hold AFRM as of Q2 2025.

  • HRT Financial reported no remaining Affirm position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 6,040 Affirm shares in Q2 2025, an estimated $313K.
  • HRT Financial first reported a position in Affirm in Q1 2021 and held it in 6 quarters.
  • HRT Financial's Affirm position peaked at $11.3M in Q4 2024.
  • 561 funds tracked by Wall St. Rank held Affirm as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.